Literature DB >> 31701188

Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Julian Kirchner1, Benedikt M Schaarschmidt2, Firas Kour2, Lino M Sawicki2, Ole Martin2, Johannes Bode3, Stephan Vom Dahl3, Verena Keitel3, Dieter Häussinger3, Christina Antke4, Christian Buchbender2, Gerald Antoch2, Philipp Heusch2.   

Abstract

OBJECTIVES: To evaluate the impact of morphological information derived from contrast-enhanced CT in the characterization of incidental focal colonic uptake in 18F-FDG PET/CT examinations.
METHODS: A total of 125 patients (female: n = 53, male: n = 72) that underwent colonoscopy secondary to contrast-enhanced, full-dose PET/CT without special bowel preparation were included in this retrospective study. PET/CT examinations were assessed for focal colonic tracer uptake in comparison with the background. Focal tracer uptake was correlated with morphological changes of the colonic wall in the contrast-enhanced CT images. Colonoscopy reports were evaluated for benign, inflammatory, polypoid, precancerous, and cancerous lesions verified by histopathology, serving as a reference standard. Sensitivity, specificity, PPV, NPV, and accuracy for detection of therapeutic relevant findings were calculated for (a) sole focal tracer uptake and (b) focal tracer uptake with correlating CT findings in contrast-enhanced CT.
RESULTS: In 38.4% (48/125) of the patients, a focal 18F-FDG uptake was observed within 67 lesions. Malignant lesions were endoscopically and histopathologically diagnosed in eleven patients, and nine of these were detected by focal 18F-FDG uptake. A total of 34 lesions with impact on short- or long-term patient management (either being pre- or malignant) were detected. Sensitivity, Specificity, PPV, NPV, and accuracy for sole 18F-FDG uptake for this combined group were 54%, 69%, 29%, 85%, and 65%. Corresponding results for focal 18F-FDG uptake with correlating CT findings were 38%, 90%, 50%, 86%, and 80%. This resulted in a statistically significant difference for diagnostic accuracy (p = 0.0001)
CONCLUSION: By analyzing additional morphological changes in contrast-enhanced CT imaging, the specificity of focal colonic 18F-FDG uptake for precancerous and cancerous lesions can be increased but leads to a considerate loss of sensitivity. Therefore, every focal colonic uptake should be followed up by colonoscopy.

Entities:  

Keywords:  18F-FDG; Colon; Contrast-enhanced CT

Mesh:

Substances:

Year:  2019        PMID: 31701188     DOI: 10.1007/s00259-019-04579-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  18F-FDG PET and PET/CT in fever of unknown origin.

Authors:  Johannes Meller; Carsten-Oliver Sahlmann; Alexander Konrad Scheel
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

2.  Colorectal Adenomas.

Authors:  Williamson B Strum
Journal:  N Engl J Med       Date:  2016-07-28       Impact factor: 91.245

3.  2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.

Authors:  Mariëtte C A van Kouwen; Fokko M Nagengast; Jan B M J Jansen; Wim J G Oyen; Joost P H Drenth
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

4.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Authors:  Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Timothy Church; Adeyinka O Laiyemo; Robert Bresalier; Gerald L Andriole; Saundra S Buys; E David Crawford; Mona N Fouad; Claudine Isaacs; Christine C Johnson; Douglas J Reding; Barbara O'Brien; Danielle M Carrick; Patrick Wright; Thomas L Riley; Mark P Purdue; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok; Christine D Berg
Journal:  N Engl J Med       Date:  2012-05-21       Impact factor: 91.245

Review 5.  Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.

Authors:  G Treglia; M L Calcagni; V Rufini; L Leccisotti; G M Meduri; M G Spitilli; D P Dambra; A M De Gaetano; A Giordano
Journal:  Colorectal Dis       Date:  2012-02       Impact factor: 3.788

6.  Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.

Authors:  Ehab M Kamel; Miriam Thumshirn; Kaspar Truninger; Marc Schiesser; Michael Fried; Barbara Padberg; Didier Schneiter; Sandro J Stoeckli; Gustav K von Schulthess; Katrin D M Stumpe
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

7.  Radiographic diagnosis of early colorectal cancer, with special reference to the superficial type of invasive carcinoma.

Authors:  M Maruyama; K Koizumi; S Kai; A Kazami; T Handa
Journal:  World J Surg       Date:  2000-09       Impact factor: 3.352

8.  The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT.

Authors:  Einat Even-Sapir; Hedva Lerman; Mordechai Gutman; Gennady Lievshitz; Limor Zuriel; Aaron Polliack; Moshe Inbar; Ur Metser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-21       Impact factor: 9.236

9.  Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.

Authors:  Harry Agress; Benjamin Z Cooper
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

10.  Long-term colorectal-cancer incidence and mortality after lower endoscopy.

Authors:  Reiko Nishihara; Kana Wu; Paul Lochhead; Teppei Morikawa; Xiaoyun Liao; Zhi Rong Qian; Kentaro Inamura; Sun A Kim; Aya Kuchiba; Mai Yamauchi; Yu Imamura; Walter C Willett; Bernard A Rosner; Charles S Fuchs; Edward Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

View more
  1 in total

1.  Reply to Letter to the Editor: "The added benefit of contrast-enhanced CT in the evaluation of incidental FDG-avid colon lesions".

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.